To hear about similar clinical trials, please enter your email below
Trial Title:
Immersive Virtual Reality Based Exersice in Post-mastectomy Lymphedema Patients
NCT ID:
NCT06553183
Condition:
Lymphedema Arm
Conditions: Official terms:
Lymphedema
Breast Cancer Lymphedema
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Treatment
Masking:
Double (Participant, Outcomes Assessor)
Intervention:
Intervention type:
Procedure
Intervention name:
immersive virtual reality
Description:
Exercise based on virtual reality video games. Immersive type will be used.
Arm group label:
study group
Intervention type:
Procedure
Intervention name:
traditional physicaltherapy
Description:
pneumatic compression, exercise and skin care
Arm group label:
control group
Arm group label:
study group
Summary:
To determine the effect of immersive virtual reality on shoulder proprioception and ROM
of post-mastectomy lymphedema patients.
Detailed description:
RESEARCH QUESTION:
Does Immersive virtual reality based exercise effective in improving shoulder
proprioception and ROM for post-mastectomy patients?
Assessment:
The digital goniometer will be used in measuring shoulder extension, flexion, adduction,
abduction, internal rotation and external rotation before the sessions and after one
month of sessions. Also, shoulder proprioception will be assessed by the digital
goniometer.The measurement will be taken for both the edematous side and the non-affected
side.
Treatment:
Study group: the patients will receive eight sessions of Immersive virtual reality based
exercise, 2 sessions per week for 4 weeks besides the traditional physical therapy.
Control group: the patients will receive eight sessions of the traditional physical
therapy, 2 sessions per week for 4 weeks.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- All the patients will be females.
- Patients with lymph node dissection.
- start at least 2 weeks after operation.
Exclusion Criteria:
- Vision problems.
- Medically instable patients.
- Balance disorders.
- Other musculoskeletal condition of shoulders.
Gender:
Female
Minimum age:
35 Years
Maximum age:
65 Years
Healthy volunteers:
No
Start date:
August 15, 2024
Completion date:
February 15, 2025
Lead sponsor:
Agency:
Cairo University
Agency class:
Other
Source:
Cairo University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06553183